Activity and safety of ipatasertib (ipat) for AKT activating mutation and/ or PTEN loss/loss of function solid tumors from MyTACTIC

Activity and safety of ipatasertib (ipat) for AKT activating mutation and/ or PTEN loss/loss of function solid tumors from MyTACTIC

Saved in:
Bibliographic Details
Published in:European journal of cancer (1990) Vol. 174; p. S71
Main Authors: VanderWalde, A., Spigel, D.R., Darbonne, W.C., Yu, W., Kim, Y., Whitehead, Z., Szado, T., Slater, D., Zuniga, R., Arrowsmith, E.
Format: Journal Article
Language:English
Published: Elsevier Ltd 01-10-2022
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
ISSN:0959-8049
1879-0852
DOI:10.1016/S0959-8049(22)00990-X